Bovine Lymphatic Tissue Extract
Bovine lymphatic tissue extract is a glandular supplement derived from cattle lymph nodes that contains bioactive nucleosides—including deoxycytidine, deoxyinosine, and thymidine—which may modulate immune function through tissue-specific activity on lymphoid tissue. Preclinical research suggests it may exert immunosuppressive effects, though human clinical evidence remains preliminary.

Origin & History
Bovine Lymphatic Tissue Extract is derived from the lymphatic tissues, such as lymph nodes or spleen, of cattle (Bos taurus). It is obtained through tissue collection from bovine carcasses, often involving dissection of lymph nodes from areas like the prescapular or flank regions, followed by purification processes to isolate bioactive fractions.
Historical & Cultural Context
No evidence of historical or traditional medicinal use in any systems (e.g., Ayurveda, TCM) was found. References to bovine lymphatic tissue are solely in modern research contexts for biological activity studies or microbial analysis.
Health Benefits
• May possess immunosuppressive properties based on preclinical animal studies (evidence: preliminary) • Contains nucleosides including deoxycytidine, deoxyinosine, and thymidine that may support cellular function (evidence: preliminary) • Shows tissue-specific activity on lymphoid tissues in laboratory settings (evidence: preliminary) • May contain novel bioactive substances beyond known nucleosides (evidence: preliminary) • Potential source of high-quality nucleic acids for research purposes (evidence: preliminary)
How It Works
Bovine lymphatic tissue extract contains nucleosides—deoxycytidine, deoxyinosine, and thymidine—that may be incorporated into cellular DNA synthesis pathways, potentially influencing lymphocyte proliferation and immune signaling. Deoxycytidine can interact with pyrimidine salvage pathways, while deoxyinosine may modulate purine metabolism, collectively affecting T-cell and B-cell activity in lymphoid tissues. The tissue-specific activity observed in preclinical models suggests the extract may act on lymphoid organ receptors or cytokine cascades, though the precise molecular targets in humans have not been characterized.
Scientific Research
No human clinical trials, RCTs, or meta-analyses have been conducted on bovine lymphatic tissue extract. The only available research is a preclinical study (PMID: 152670) that examined a highly purified extract from bovine spleen in animal models, demonstrating tissue-specific immunosuppressive activity on lymphoid tissues.
Clinical Summary
Research on bovine lymphatic tissue extract is largely limited to preclinical animal studies, with no large-scale randomized controlled human trials published to date. Animal models have demonstrated immunosuppressive properties, suggesting potential utility in conditions of immune overactivation, but effect sizes and mechanistic data have not been replicated in human subjects. The nucleoside content—specifically deoxycytidine and thymidine—provides a plausible biochemical rationale for cellular support, yet quantified human outcomes such as changes in lymphocyte counts or cytokine levels are absent from the published literature. Overall, evidence quality is rated as preliminary, and broader clinical validation is necessary before therapeutic claims can be substantiated.
Nutritional Profile
Bovine lymphatic tissue extract is a protein-rich biological extract derived from bovine lymphoid tissue, containing nucleosides such as deoxycytidine, deoxyinosine, and thymidine alongside peptides and other biomolecules characteristic of lymphatic tissue. As a glandular extract, it provides small regulatory proteins and nucleotide precursors that may influence immune cell function, supported by preliminary preclinical evidence for tissue-specific immunomodulatory activity on lymphoid tissues.
Preparation & Dosage
No clinically studied dosage ranges, forms, or standardization details are available as human trials have not been conducted. Consult a healthcare provider before starting any new supplement.
Synergy & Pairings
Thymus extract, Spleen extract, Colostrum, Beta-glucans, Transfer factors
Safety & Interactions
Bovine lymphatic tissue extract carries a theoretical risk of pathogen transmission, including prion diseases such as bovine spongiform encephalopathy (BSE), making sourcing from certified BSE-free herds a critical safety consideration. Individuals taking immunosuppressive medications such as corticosteroids, cyclosporine, or methotrexate should exercise caution, as additive immunosuppression could increase susceptibility to infection. The extract is contraindicated or should be used only under medical supervision during pregnancy and lactation due to unknown effects on fetal immune development and a lack of safety data in these populations. People with autoimmune conditions should consult a healthcare provider before use, as immune modulation could unpredictably alter disease activity.